Integrated Diagnostics Holdings plc (FRA:8I8)

Market Cap	337.30M
Revenue (ttm)	116.15M
Net Income (ttm)	18.84M
Shares Out	n/a
EPS (ttm)	0.03
PE Ratio	17.90
Forward PE	13.31
Dividend	0.01 (2.82%)
Ex-Dividend Date	Sep 11, 2025

Volume	n/a
Average Volume	205
Open	0.5450
Previous Close	0.5450
Day's Range	0.5450 - 0.5450
52-Week Range	0.2320 - 0.6100
Beta	n/a
RSI	55.16
Earnings Date	Apr 8, 2026

About FRA:8I8

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Medical Laboratories
• Founded: 1979
• Employees: 6,309
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8I8

Financial Performance

In 2024, FRA:8I8's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP